Near normalization of final height with adapted doses of growth hormone in Turner's syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 5, 1998, Pages 1462-1466

  Carel, Jean Claude ^a   Mathivon, Laurence ^a   Gendrel, Christine ^a,b   Ducret, Jean Pascal ^b   Chaussain, Jean Louis ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GROWTH HORMONE; MAXOMAT; RECOMBINANT GROWTH HORMONE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BODY HEIGHT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERABILITY; ESTROGEN THERAPY; FEMALE; GROWTH RATE; HUMAN; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT PLANNING; TURNER SYNDROME;

ADOLESCENT; AGE DETERMINATION BY SKELETON; BODY HEIGHT; CHILD; ESTROGENS; FEMALE; HUMAN GROWTH HORMONE; HUMANS; TURNER SYNDROME;

EID: 0031754334     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.5.1462     Document Type: Article

References (35)

1. Lippe B. 1991 Turner syndrome. Endocrinol Metab Clin North Am. 20:121-152.
2. Ranke MB, Grauer ML. 1994 Adult height in Turner syndrome: results of a multinational survey. Horm Res. 42:90-94.
3. Saenger P. 1996 Turner's syndrome. N Engl J Med. 23:1749-1754.
4. Rochiccioli P, David M, Malpuech G, et al. 1994 Study of final height in Turner's syndrome. Ethnic and genetic influences. Acta Paediatr. 83:305-308.
5. Sempé M, Hansson Bondallaz C, Limoni C. 1996 Growth curves in untreated Ullrich-Turner syndrome: French reference standards 1-22 years. Eur J Pediatr. 155:862-869.
6. Cabrol S, Saab C, Gourmelen M, Raux-Demay MC, Le Bouc Y. 1996 Syndrome de Turner: croissance staturopondérale et maturation osseuses spontanées. Arch Pediatr. 3:313-318.
7. Sempé M, Pédron G, Roy P. 1979 Auxologie, méhodes et séquences. Paris: Theraplix.
8. Rati S, Moore WV, Van Vliet G, Kaplan SL. 1986 Growth stimulating effects of human growth hormone therapy in patients with Turner syndrome. J Pediatr. 109:944-949.
9. Ross JL, Long LM, Skerda MC, Cassorla F, Loriaux DL, Cutler Jr GB. 1986 Growth response relationship between growth hormone dose and short-term growth in patients with Turner's syndrome. J Clin Endocrinol Metab. 63:1028-1033.
10. Vanderschueren-Lodeweyckx M, Massa G, Maes M, et al. 1990 Growth-promoting effects of growth hormone and low dose estradiol in girls with Turner's syndrome. J Clin Endocrinol Metab. 70:122-126.
11. Haeusler G, Frisch H. 1994 Methods for evaluation of growth in Turner's syndrome: critical approach and review of the literature. Acta Paediatr. 83:309-314.
12. Chipman JJ. 1993 Study design for final height determination in Turner syndrome: pros and cons. Horm Res. 39(Suppl 2):18-22.
13. Rochiccioli P, Battin J, Bertrand AM, et al. 1995 Final height in Turner syndrome patients treated with growth hormone. Horm Res. 44:172-176.
14. Van den Broeck J, Massa G, Attanasio A, et al. 1995 Final height after long-term growth hormone treatment in Turner syndrome. European Study Group. J Pediatr. 127:729-735.
15. Nilsson KO, Albertsson-Wikland K, Aim J, et al. 1996 Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone. J Clin Endocrinol Metab. 81:635-640.
16. Attanasio A, James D, Reinhardt R, Rekers Mombarg L. 1995 Final height and long-term outcome after growth hormone therapy in Turner syndrome: results of a German multicentre trial. Horm Res. 43:147-149.
17. Massa G, Otten BJ, De Muinck Keizer-Schrama SMPF, et al. 1995 Treatment with two growth hormone regimens in girls with Turner syndrome: final height results. Dutch Growth Hormone Working Group. Horm Res. 43:144-146.
18. Rosenfeld RG, Frane J, Attie KM, et al. 1992 Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. J Pediatr. 121:49-55.
19. Taback SP, Collu R, Deal CL, et al. 1996 Does growth-hormone supplementation affect adult height in Turner's syndrome. Lancet. 348:25-27.
20. Donaldson MD. 1996 Jury still out on growth hormone for normal short stature and Turner's syndrome. Lancet. 348:3-4.
21. Lyon AJ, Preece MA, Grant DB. 1985 Growth curve for girls with Turner syndrome. Arch Dis Child. 60:932-935.
22. Greulich WW, Pyle SI. 1959 Radiographic atlas of skeletal development of the hand and wrist. Stanford: Stanford University Press.
23. Chaussain J-L, Gendrel C, Job B, Ducret JP. 193 Optimization of the dose of growth hormone in girls with Turner syndrome. In: Hibi I, Takano K eds. Basic and clinical approach to Turner syndrome. Amsterdam: Elsevier; 273-278.
24. Chatelain PG, van Wijk PA, Copeland KC, Blethen SL, Underwood LE. 1983 Effect of in vitro action of serum proteases or exposure to acid on measurable immunoreactive somatomedin-C in serum. J Clin Endocrinol Metab. 56:376-383.
25. Takano K, Shizume K, Hibi I, et al. 1993 Growth hormone treatment in Turner syndrome: results of a multicentre study in Japan. The Committee for the Treatment of Turner Syndrome. Horm Res. 39(Suppl 2):37-41.
26. Van Teunenbroek A, De Muinck Keizer-Schrama SMPF, Stijnen T, et al. 1996 Yearly stepwise increment of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. J Clin Endocrinol Metab. 81:4013-4021.
27. Spoudeas HA, Motta RM, Stanhope R, Hindmarsh PC, Brook CGD. 1993 Therapeutic options for promoting growth in the Turner syndrome. In: Hibi Takano K, eds. Basic and clincal approach to Turner syndrome. Amsterdam: Elsevier; 323-326.
28. Rongen-Westerlaken C, van Es A, Wit JM, et al. 1992 Growth hormone therapy in Turner's syndrome. Impact of injection frequency and initial bone age. Am J Dis Child. 146:817-820.
29. De Schepper J, Craen M, Massa G, et al. 1994 Growth hormone therapy in Turner's syndrome: one vs. two daily injections. J Clin Endocrinol Metab. 79:489-494.
30. Naeraa RW, Nielsen J, Kastrup KW. 1994 Growth hormone and 17β-oestradiol treatment of Turner girls-2-year results. Eur J Pediatr. 153:72-77.
31. Massa G, Maes M, Heinrichs C, Vandeweghe M, Craen M, Vanderschueren-Lodeweyckx M. 1993 Influence of spontaneous or induced puberty on the owth promoting effect of treatment with growth hormone in girls with Turner's syndrome. Clin Endocrinol (Oxf). 38:253-260.
32. Rongen-Westerlaken C, Wit JM, De Muinck Keizer-Schrama SMPF, et al. 1992 Growth hormone treatment in Turner syndrome accelerates growth and skeletal maturation. Dutch Growth Hormone Working Group. Eur J Pediatr. 151:477-481.
33. Joss E, Zupinger K. 1984 Oxandrolone in girls with Turner's syndrome. Acta Paediatr Scand. 73:674-679.
34. Sacks H, Chalmers TC, Smith Jr H. 1982 Randomized vs. historical controls for clinical trials. Am J Med. 72:233-240.
35. Attie KM, Frane JW. 1997 Accuracy of adult height prediction methods for Turner syndrome using U.S. untreated control data. Horm Res. 48S2:60.